Q2 2025 Treace Medical Concepts Inc Earnings Call Transcript
Key Points
- Treace Medical Concepts Inc (TMCI) reported a 7% increase in revenue for the second quarter of 2025, reaching $47.4 million.
- The company successfully reduced operating expenses by 4% compared to the same quarter in 2024, reflecting effective expense management initiatives.
- TMCI achieved a significant improvement in adjusted EBITDA loss, reducing it by 58% compared to the second quarter of 2024.
- The company expanded its portfolio with three new bunion correction systems, enhancing its position as a comprehensive bunion solutions provider.
- Surgeon enthusiasm and patient outcomes have been positive during the limited releases of new systems, indicating strong market acceptance and potential for growth.
- Despite revenue growth, TMCI reported a net loss of $17.4 million for the second quarter of 2025.
- Gross margin slightly decreased to 79.7% from 80.2% in the second quarter of 2024.
- Cash equivalents and marketable securities decreased to $69.3 million as of June 30, 2025, from $76.1 million as of March 31, 2025.
- The company faces challenges in penetrating the remaining 70% of bunion-related cases among its existing surgeon customer base.
- Market trends indicate some elective procedures are being pushed out, potentially impacting short-term revenue growth.
Good day and thank you for standing by. Welcome to the Treace Medical Concepts, 2nd quarter 2025 earnings conference call. (Operator Instructions)
Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Trip Taylor, Investor relations. Please go ahead.
Good afternoon everyone and welcome to our 2nd quarter 2025 earnings conference call. Participating from the company today will be John Treese, Chief Executive Officer, and Mark Hare, Chief Financial Officer. During the call, John will offer commentary on our commercial activities, followed by Mark for a review of our 2nd quarter financial results released after market closed today.
We will post a question and answer session following our prepared remarks. Our press release can be found on the investor relations section of our website at investors.tre.com. This call is being recorded and will be archived in the investor section of our website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
